CoroCompass is a clinical decision support tool for cardiologists, providing guideline-based risk assessment and lipid management calculators on iOS.
The App DNA
What makes this app unique?
Clinicians need to perform rapid, guideline-aligned risk stratification during patient visits without the latency or privacy risks of cloud-based calculators.
For Cardiology clinicians and healthcare providers requiring rapid, guideline-based risk assessment tools for primary prevention.
What does it look like?
Key features
Calculates 10-year cardiovascular risk using integrated guideline-based risk enhancers.
Maps Agatston scores and patient demographics to MESA percentiles and risk categories.
Generates text-based summaries with statin and aspirin therapy recommendations based on ACC/AHA guidelines.
Performs all clinical calculations locally on the device without requiring an internet connection.
How much does it cost?
CoroCompass is currently offered as a free utility with no visible monetization or subscription gates.
Velocity
Maintenance developmentnew contentperformanceShow more...
The app has shipped only one release in the last 181 days, placing it firmly in a maintenance cycle. Development is currently focused on clinical guideline integration and minor performance adjustments rather than frequent feature iteration. The latest release updated the user agreement and clinical data, but the long interval between updates indicates a lack of active development momentum.
Who built it?
KENNETH SCOTT GUBER
3 apps tracked · Medical
EF-ortless Echo Trainer
CardioTrials.AIUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for CoroCompass CV Risk Prevention
How's the Medical market?
CoroCompass operates as a specialized medical utility, currently ranking #41 in its specific medical sub-category. The lack of a monetization layer suggests a brand-building or professional-utility focus rather than immediate revenue capture.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CoroCompass CV Risk Prevention
Where is it heading?
The medical utility market is shifting toward privacy-compliant, offline-capable tools that integrate into existing clinical workflows. CoroCompass is well-positioned to serve this segment, provided it maintains a rigorous update cycle to match evolving ACC/AHA guidelines.
- The 6-month update cadence indicates a maintenance-mode posture, which is sufficient for stable guidelines but risky if clinical standards shift rapidly.
- Local-only processing addresses the growing clinician demand for data privacy, creating a defensible niche against cloud-heavy medical reference rivals.
The SWOT
- Offline-first processing removes connectivity dependency
- Local-only calculation ensures patient data privacy
- EHR-compatible export formats could drive institutional adoption
- Expansion into secondary prevention risk calculators
Next best moves
Ship EHR-compatible clinical summary exports because clinicians report manual data entry as a primary workflow friction → increase professional utility
+ 1 more prioritized moveThe counter-intuitive read
The lack of monetization is a strategic advantage…
Read the full takeBottom line
CoroCompass provides high-utility, offline-first clinical support that builds professional trust through privacy-first design. Strengthening EHR integration would unlock institutional adoption, moving the app from a personal reference tool to a standard clinical workflow component.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated